comparemela.com

Latest Breaking News On - Continuous subcutaneous insulin infusion - Page 1 : comparemela.com

CGM Associated With Lower Retinopathy Risk in T1D

The use of continuous glucose monitoring (CGM) was linked to a reduced risk for diabetic retinopathy, a debilitating complication in adults with type 1 diabetes.

Johns hopkins universityUnited statesYan alvin liuLos angelesEstellem everettDavid geffen school of medicineUniversity of californiaJohns hopkins university school of medicineDiabetes centerWilmer eye institute in baltimoreWilmer eye instituteJohns hopkins endocrineDavid geffen schoolTin yan alvin liuJohns hopkins university schoolDiabetes mellitus type 1

Automatic Hybrid Insulin Delivery Systems Help Manage T1D

A prospective evaluation by 16 diabetes specialists in Spain suggests that advanced hybrid closed-loop systems improve glycemic control in patients with type 1 diabetes.

Comunidad autonoma de extremaduraUnited statesPilar beatoBadajoz university hospitalAmerican diabetes associationSpanish diabetes societyNational institute for healthNational instituteCare excellenceDiabetes mellitus type 1Iabetes mellitus type iType 1 diabetesYpe 1 dmDiabetes mellitusInsulin pumpContinuous subcutaneous insulin infusion

Tandem Insulin Pump System Integrates With Libre Sensor

Tandem Diabetes Care's t:slim X2 insulin pump becomes the first to integrate with Abbott's FreeStyle Libre 2 Plus Sensor for US users.

United statesUs food drug administrationTandem diabetes carePump automated insulin delivery systemAbbott freestyle libreFreestyle libreDrug administrationMedscape medicalDiabetes mellitus type 1Iabetes mellitus type iType 1 diabetesYpe 1 dmInsulin pumpContinuous subcutaneous insulin infusionWashington dcWashington district of columbia

Cyberattacks Challenge Canadian Health Information Systems

A new analysis recommends a four-stage plan for physicians and health systems to improve their cybersecurity practices.

Vinyas harishAlex wilnerCarleton universityCanadian medical protective associationInternational securityOntario medical associationHealth canadaUniversity of toronto institute healthOntario healthHealth policyMedscape medicalInfrastructure protectionCybersecurity collaborative specializationHealthcare technologyEalth care technologyElectronic medical record emr

Insulet Shares Slump on Concerns of New Diabetes Drugs Sales

Insulet Corp s shares hit an over 3-year low on Thursday on concerns that strong demand for a new class of diabetes drugs that also aid in weight loss could hit sales of its insulin pumps.

Shinjini ganguliJames hollingsheadBhanvi satijaNovo nordiskInsulet corpWells fargo healthcare conferenceNew england journalMassachusetts based insuletAnild silvaWeight managementDiabetes mellitus type 1Iabetes mellitus type iType 1 diabetesGlp 1 receptor agonistsGlucagon like peptide 1 receptor agonistsIncretin hormones

vimarsana © 2020. All Rights Reserved.